Glycopyrrolate Injection
Product Images NDC 70700-903

This is a description of a medication called Novaplus with dosage information. It should not be used in newborns and contains benzyl alcohol. It is intended for intramuscular or intravenous administration and includes instructions for storage. The medication is manufactured by Xiromed, in India.*

This is a drug product called "novaplus™" containing 4 mg of medication within a 20 mL multiple dose vial (0.2 mg/mL). It is for intramuscular or intravenous administration and contains Benzyl Alcohol as a preservative. The drug also contains Water for Injection, USP q.s. and its pH is adjusted using hydrochloric acid and/or sodium hydroxide. The package insert provides information on the typical dosage. The drug is not recommended for neonates and should be stored at 20° to 25°C (68° to 77°F). The manufacturing company is Xiromed, LLC, located in Florham Park, NJ, USA, and the product is made in India. No information is provided about the product's therapeutic indication or target.*

This is a description of a Novaplus injection solution with a strength of 1mg/5ml contained in a 5mlL Multiple Dose Vial. It is manufactured in India with a product code of TS/DRUGS/2/2015 and is distributed by Xiromed, LLC in Florham Park, NJ. The injection contains Benzyl Alcohol and is intended for intravenous or intramuscular administration. It should not be used in newborns. The lot number and expiration date are specified on the packaging. The package insert should be consulted for usual dosage. The injection should be stored at a temperature between 20° to 25°C (68° to 77°F).*